Eric D FaderEric Fader has represented health care providers and other corporate clients in connection with business planning and contractual issues, transactional matters, and federal and state regulatory compliance for more than 30 years.
His clients includ providers of intraoperative neurophysiologic monitoring (IONM) services, telehealth and telepharmacy companies, urgent care facilities, imaging centers, and private practices of all types. Eric has also represented insurers and third-party administrators, provider networks, medical device suppliers, equipment vendors, and providers of electronic medical records and other online health care services in contractual and regulatory matters. Eric advises on billing and reimbursement questions, federal and state anti-kickback and self-referral issues, HIPAA compliance (including privacy and data breaches), payor audits, hospital privilege and medical staff issues, and state licensure and certificate of need matters. His work also includes organizational matters, corporate governance and structuring/restructuring advice, operating agreements, shareholder and partnership agreements and disputes, labor and employment law issues, private securities offerings, joint ventures, mergers, and acquisitions.
A frequent writer and commentator on health care issues, Eric has written for and has been quoted in Bloomberg BNA, Law360 and Thomson Reuters Westlaw, among many others. Eric is the Editor of Rivkin Rounds, an electronic news bulletin for businesses, professionals, investors, and stakeholders in the health care industry.
Eric is a member of the American Society of Neurophysiological Monitoring (ASNM) and has been a webinar and symposium speaker for the ASNM. He served on the Board of Directors of Stayhealthy, Inc., a privately owned health solutions company committed to changing the way the world measures health and fitness.
Eric began his legal career as a securities lawyer and moonlighted for several years as a professional microcap stock trader. This activity afforded him unusual insights into the OTC markets which he has used in representing small public companies and those that invest in them. Read More Read Less